论文常用三线表模板5030

1、表1护士一般资料情况n=500工程组别频数构成比为性别女47895.6男224.4年龄段岁<2414929.8252919639.2>3015531.0婚姻状况单身26052.0已婚24048.0护龄年<527054.061011523.0>1111523.0学历中专193.8大专22244.4本科25150.2硕士81.6职称护士21442.8护师21042.0主管护师6913.8副主任护师71.4月夜班次数0次5811.61欷27955.84次及以上16332.6个人年收入元<4万15430.846万19639.2)6万15030.0科室专科19939.8非专

2、科30160.2表5不同年龄段护士专业生活质量得分的比拟X生年龄段n=500维度<24岁(n=149)2529岁>30岁(n=155)FP(n=196)同情满意32.17±7.1131.06±8.0532.42±7.611.6100.201职业倦怠27.53±4.5127.04±4.3227.95±4.771.7870.169继发性创伤应激21.71+5.7322.41+5.3123.29+5.871*3.0240.049专业生活质量总分81.41+12.5580.50±12.7183.66±13.26

3、2.6990.068*P<0,05;124表3不同组小鼠肝脏P-JNK平均灰度值结果比拟x土S)例数P-JNKFPA组正常组8118.99+5.95B组模型对照组8101.05+5.20aC组(DMSC&)8102.11+5.63b15.386*<0.001D组低剂量SP600125组8107.96+5.36cE组高剂量SP600125组8113.96+5.50c,d注：*P<0.05;a与正常组比拟,P<0.05;b与模型对照组比拟,P0.05;°与DMSCfi比拟,P<0.05;d与低剂量组比拟,P<0.05.表3干预组与对照组与减肥支

4、持者沟通情况比拟工程类别(n=65).(n=63)2XPn%n%锻炼减肥支持者人父母3558.33555.6老师11.534.8同学23.134.8父母/老师57.711.60.510父母/老师/同学1827.71523.8其他46.269.5沟通频率人2233.81727.0至少每天一次2233.81930.20.321至少每个星期一两次812.31727.0至少每个月一两次46.246.3至少每年一两次913.869.5至少一年一次沟通满意度不满意710.8711.1中立2944.63454.01.3270.515满意2944.62234.9注："Fisher确切概率法,非参数检

5、验.表5不同测量指标ROC®线下面积比拟结果方法指标面积标准误95%)I彩色多普勒RI0.7900.0460.7010.880PSV0.6330.0560.5230.743EDV0.7550.0470.6630.848三维能量多普勒VI0.9080.0310.8480.968FI0.6440.0590.5270.760VFI0.8800.0360.8110.950表1两种治疗方法疗效评分比拟疗效评分土S治疗时间药物+激光药物(n=30)t值P(n=31)18.77±0.43a8.90±0.31b-1.3310.1892月7.19±0.808.00

6、7;0.46-4.894<*0.0013月6.23±0.997.00±0.46-3.944<*0.001111i<_*0.05注：a、b分别表示两种治疗方法第i个月的疗效评分与治疗前比拟差异有统计学意义.*P<0.05表13Logistic回归变量含义及赋值说明变量名称赋值说明Y同情疲劳分度无=0,轻度=1,中度=2,重度=3X年龄段<24岁=1=Xii,2529岁=2=Xm>30岁=3=Xi3%文化程度中专=1=X21,大专=2=X22,本科及以上=3=X23X护龄05年=1=X31,610年=2=X32,A11年=3=X33%职称护士

7、=1=X41,护师=2=X42,主管护师/副主任护师=3=X43X年收入<4万=1=X51,46万=2=X52,>6万=3=X53X科室非专科=0,专科=1表14无序多分类logistic回归分析结果112WaldxPOR95泡IY=1年龄段参照组=<24岁轻度同情2529岁0.760.451.520.222.13(0.885.16)疲劳>30岁0.060.540.010.921.06(0.373.05)文化程度参照组=中专大专0.790.377.09*<0.012.20(1.06*4.55)本科及以上0.890.397.47*<0.012.43(1.13*

8、5.23)护龄参照组=05年610年0.800.472.510.112.23(0.885.59)>11年0.230.380.100.751.25(0.592.65)职称参照组=护士护师-0.860.631.900.170.44(0.121.44)主管护师及以上0.040.930.010.921.04(0.176.45)年收入参照组=<4万46万0.380.390.150.701.46(0.683.14)6万0.860.571.520.222.36(0.777.22)科室参照组=非专科-0.090.470.040.850.91(0.362.29)年龄段参照组=<24岁Y=2中度

9、同情疲劳2529岁>30岁0.53-0.650.580.600.820.660.370.421.69(0.540.52(0.165.33)1.69)文化程度参照组=中专大专0.860.4116.45*<0.012.36(1.055.27)本科及以上0.910.4317.44*<0.012.48(1.075.77)护龄参照组=05年610年0.790.493.050.082.20(0.845.75)>11年0.540.351.350.251.71(0.863.41)职称参照组=护士护师-0.330.590.310.580.72(0.272.59)主管护师及以上-0.020

10、.890.010.920.98(0.175.72)年收入参照组=<4万46万0.510.460.640.421.66(0.684.10)6万1.150.544.50*0.033.16(1.099.10)科室参照组=非专科0.160.450.130.721.18(0.492.81):以Y=0无同情疲劳作为参照组,拟合Y=1,2,3时的多分类logistic回归方程.*:p<0.05.表1两组乳腺癌患者体温结果比拟x士S,C组别例数术前1天手术日术后1天术后3天术后7天观察组3036.6+0.236.3+0.4*36.1+0.2*36.3+0.336.4+0.4对照组3036.6+0.

11、236.2+0.4八35.2+0.3八35.9+0.4a36.3+0.3注：*与对照组比拟,P<0.05;与术前1天比拟,P<0.05o表2两组乳腺癌患者不同时间血压、心率结果比拟又士S指标别术前1天手术日术后1天术后3天术后7天观察117.64+10.28146.46+12.11八127.31+12.27八114.82+7.64八120.13+9.16SBP组(mmHg)对昭八、149.24±7.22*161.74±8.33*156.24+7.61*151.37+6.34149.04+6.77组观察78.16+8.1876.89±8.6377.97+

12、9.2678.54+6.4379.08+7.86DBP组(mmHg)对昭八、76.16+8.1886.53+9.3476.01+8.6674.32+7.8273.65+8.02组观察75.08+4.74112.06+10.2780.76+7.7378.28+3.6778.41+7.24HR组次/min)对昭八、76.08+4.74117.95+8.3485.24+3.8280.46+3.8379.14+3.55组注：*与对照组比拟,P<0.05;与术前1天比拟,P<0.05表4两组乳腺癌患者不同时间CRPIL-6、TNF-%结果比拟7士S指标组别例数术前1天术后1天术后3天CRP观

13、察组301.26+0.98*8.76+2.62*6.73+1.95(mg/L)对照组300.98+0.4611.75+3.179.69+2.68IL-6观察组304.57+1.41*5.98+5.62*3.15+2.48(pg/mL)对照组304.83+1.496.86+3.765.07+3.07TNF-a观察组308.11+2.17*8.57+2.17*8.21+1.73(pg/mL)对照组307.22+1.4210.94+3.249.31+2.43注：*与对照组比拟,一P<0.05;与术前1天比拟,P<0.05.表1联合组和单用组患者治疗前后细胞因子比拟(x±S)组别

14、例TNF-a(ng/L)IL-6(ng/L)IL-18(ng/L)数联合组5072.32+22.8731.01+12.45s350.10+38.74107.91+18.39a61.10+20.7433.91+15.39a单用组5070.31+21.7548.53+15.51a346.04+37.65162.32+20.40a63.04+21.6541.32+18.40at0.4506.2290.53114.0080.4582.184P0.653*<0.0010.596*<0.0010.648*0.031注：联合组为参附+乌司他丁,单用组为乌司他丁;P<0.05;a表示同组内同

15、类细胞因子与治疗前比拟P<0.052.31 白细胞参数对照组WBCAN徵于术后1、3天比术前1天明显升高P<0.05.观察组WBCANO没有显着变化P>0.05.2.32 红细胞参数对照组RBCHb、HCT3个红细胞参数在手术后1、3天较术前一天显着降低P<0.05;MCVMCHMCH这3个红细胞形态参数在术后几个时间点内较术前水平差异均无显着性P>0.05,只有RDWASDfi于术后一天较术前一天明显增大P<0.05表3.表3两组乳腺癌患者不同时间血常规结果比拟士S指标组别例数术前1天术后1天术后3天WBC观察组308.25±1.20*9.16+

16、1.15*8.64+1.33(X109/L)对照组308.23±1.1613.81+1.27八11.42+4.64八RBC观察组304.32±0.244.58+0.194.60+0.20(X1012/L)对照组304.26+0.293.19+0.263.60+0.31Hb观察组30120.07±5.77116.63+5.84117.16+5.37(g/L)对照组30118.08+5.79103.27+8.13八110.43+8.76八观察组300.37+0.020.36+0.030.36+0.02HCT对照组300.38+0.030.31+0.02八0.32+0.03八MCV观察组3079.64+7.7280.72+6.2080.56+5.46(fL)对照组3078.85+8.1183.33+6.7480.99+7.32MCH观察组3028.25+1.2030.36+1.1530.64+1.33(Pg)对照组3027.27+1.1628.18+1.6727.73+1.834MCHC观察组30324.32+9.24334.58+9.19341.60+9.20(g/L)对照组30334.46+9.29336.01+9.26334.70+9.41RDW-SD观察组3037.69+5